Client-Pharma is proud to announce the expansion of its dedicated clinical trial supply services in China after finalizing contracts and agreements with trusted partners during its latest trip to Shanghai.
Gary Campbell, CEO of Client-Pharma explains, “China is the world’s second largest pharmaceutical market, behind the United States, and it is well documented that the regulatory changes in regional government policy have been a catalyst for encouraging innovation, embracing technology and expediting drug development and clinical trials.
For a number of years, we have forged great relationships with colleagues in the emerging Chinese pharma sector. This new partnership for clinical trial commercial drug procurement, storage and distribution will enable Client-Pharma to expand its access to a wide-reaching and thorough direct delivery network to 27,000 medical institutions bridging 31 provinces, municipalities and autonomous regions. The facility in Shanghai provides more than 5,000m2 of specialist temperature-specific storage components for clinical trial services in China.
Our aim is always to ensure a high level of quality assurance throughout our audited supply network and our new Regional Distribution Center in China will continue to enable us to do this.”
